MDU RESOURCES GROUP INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MDU RESOURCES GROUP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.88B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.76B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.80B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.75B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $3.45B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $1.39B | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $1.59B | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $1.36B | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $1.20B | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $1.38B | Feb 19, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.86B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.75B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.81B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.75B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $3.40B | Feb 22, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $190.40M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $281.11M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $414.71M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $367.49M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $378.13M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $112.29M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $153.08M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $99.70M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $25.13M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $95.07M | Feb 19, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $290.38M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $265.64M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $224.94M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $200.87M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $331.05M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $145.89M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $203.71M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $138.25M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $57.07M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $130.22M | Feb 19, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $433.02M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $414.49M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $407.08M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $379.95M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.21B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $4.03B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $3.90B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $3.26B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $3.14B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $2.89B | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $473.37M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $502.32M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $332.63M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $510.06M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $495.78M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $768.37M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $542.28M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $499.88M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $448.01M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $462.21M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.62B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $7.04B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $7.83B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $9.66B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $8.91B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $8.05B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $7.68B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $6.99B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $6.33B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $6.28B | Feb 22, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.77B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.69B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $2.91B | Feb 20, 2026 |
| FY2025 | Dec 31, 2022 | $3.59B | Feb 20, 2026 |
| FY2024 | Dec 31, 2021 | $3.38B | Feb 20, 2025 |
| FY2021 | Dec 31, 2020 | $3.08B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $2.85B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.57B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $2.43B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $2.32B | Feb 23, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $345.74M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $345.74M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $345.74M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $488.96M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $765.39M | Feb 24, 2023 |
| FY2022 | Dec 31, 2020 | $714.96M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $681.36M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $664.92M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $631.79M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $631.79M | Feb 22, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.03B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $1.25B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.95B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.76B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.56B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.34B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.16B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $1.04B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $912.28M | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.21M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $66.90M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $60.47M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $70.43M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $54.16M | Feb 24, 2023 |
| FY2022 | Dec 31, 2020 | $59.55M | Feb 24, 2023 |
| FY2022 | Dec 31, 2019 | $66.46M | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $53.95M | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $34.60M | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | $46.11M | Feb 21, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.68B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.29B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $2.17B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $2.37B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.74B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $2.21B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $2.24B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.11B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $1.71B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.79B | Feb 23, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |